BMY SEC filings last scanned 22 Aug 2026, 16:41 UTC
CEO Timeline
Christopher Boerner, Ph.D.Current
Nov 2023 — Present(2y 10mo)
Christopher Boerner, Ph.D., was appointed Chief Executive Officer of Bristol Myers Squibb, effective November 1, 2023, succeeding Giovanni Caforio.
2 source filings — click to expand
Giovanni Caforio
May 2015 — Nov 2023(8y 6mo)
Giovanni Caforio, M.D., Chief Operating Officer of Bristol-Myers Squibb Company, was designated as Chief Executive Officer, effective May 5, 2015.
planned retirement
4 source filings — click to expand
Lamberto Andreotti
May 2010 — May 2015(5y)
Lamberto Andreotti was appointed Chief Executive Officer of Bristol-Myers Squibb Company, effective May 4, 2010, succeeding James M. Cornelius.
retirement
5 source filings — click to expand
James M. Cornelius
Sep 2006 — May 2010(3y 8mo)
James M. Cornelius was appointed as Interim Chief Executive Officer of Bristol Myers Squibb, effective September 12, 2006, following the termination of Peter R. Dolan.